WHO ICTRP trial
A study to assess the usefulness of using genetics to improve prescribing
ISRCTN14050335 · International Standard Randomised Controlled Trial Number (ISRCTN) · Recruiting
Key facts
| Trial ID | ISRCTN14050335 |
|---|---|
| Public title | A study to assess the usefulness of using genetics to improve prescribing |
| Scientific title | A cross-sectional trial assessing the clinical utility of pre-emptive pharmacogenetic testing in primary and secondary care: the Implementing Pharmacogenetics to Improve Prescribing (IPTIP) trial |
| Primary sponsor | University of Manchester |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | United Kingdom;England |
| Conditions | Pre-emptive pharmacogenetic testing Not Applicable |
| Interventions | This is an observational study recruiting across two study arms, inpatient (IPTIP-I) and outpatient (IPTIP-O). The information gathered at recruitment will be sufficient for the electronic platform to generate a study ID, allowing 3 ml of… |
| Registration date | Jun 23, 2022 |
| Target size | 646 |
| Secondary IDs | Nil known;Nil known;NIHR301748, IRAS 305751, CPMS 51741 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: